ARTICLE | Company News
Adenosine cardiovascular news
April 8, 2013 7:00 AM UTC
Adenosine engaged Needham to explore strategic alternatives for Stedivaze apadenoson, which could include regional or global partners. Stedivaze is an adenosine A2A receptor (ADORA2A) agonist in Phase III trials for use as a pharmacological stress agent in myocardial perfusion imaging (MPI). ...